1. Home
  2. LYV vs ICUCW Comparison

LYV vs ICUCW Comparison

Compare LYV & ICUCW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LYV
  • ICUCW
  • Stock Information
  • Founded
  • LYV 2005
  • ICUCW N/A
  • Country
  • LYV United States
  • ICUCW United States
  • Employees
  • LYV N/A
  • ICUCW 12
  • Industry
  • LYV Services-Misc. Amusement & Recreation
  • ICUCW Biotechnology: Pharmaceutical Preparations
  • Sector
  • LYV Consumer Discretionary
  • ICUCW Health Care
  • Exchange
  • LYV Nasdaq
  • ICUCW Nasdaq
  • Market Cap
  • LYV N/A
  • ICUCW N/A
  • IPO Year
  • LYV N/A
  • ICUCW 2021
  • Fundamental
  • Price
  • LYV $132.59
  • ICUCW $0.03
  • Analyst Decision
  • LYV Strong Buy
  • ICUCW
  • Analyst Count
  • LYV 16
  • ICUCW 0
  • Target Price
  • LYV $144.63
  • ICUCW N/A
  • AVG Volume (30 Days)
  • LYV 2.5M
  • ICUCW N/A
  • Earning Date
  • LYV 11-11-2024
  • ICUCW N/A
  • Dividend Yield
  • LYV N/A
  • ICUCW N/A
  • EPS Growth
  • LYV N/A
  • ICUCW N/A
  • EPS
  • LYV 0.89
  • ICUCW N/A
  • Revenue
  • LYV $23,315,469,000.00
  • ICUCW N/A
  • Revenue This Year
  • LYV $2.91
  • ICUCW N/A
  • Revenue Next Year
  • LYV $14.88
  • ICUCW N/A
  • P/E Ratio
  • LYV $149.45
  • ICUCW N/A
  • Revenue Growth
  • LYV 9.99
  • ICUCW N/A
  • 52 Week Low
  • LYV $86.67
  • ICUCW N/A
  • 52 Week High
  • LYV $141.18
  • ICUCW N/A
  • Technical
  • Relative Strength Index (RSI)
  • LYV 47.57
  • ICUCW N/A
  • Support Level
  • LYV $133.80
  • ICUCW N/A
  • Resistance Level
  • LYV $138.56
  • ICUCW N/A
  • Average True Range (ATR)
  • LYV 2.81
  • ICUCW 0.00
  • MACD
  • LYV -1.23
  • ICUCW 0.00
  • Stochastic Oscillator
  • LYV 6.30
  • ICUCW 0.00

About ICUCW SeaStar Medical Holding Corporation Warrant

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.

Share on Social Networks: